Trials / Completed
CompletedNCT06459375
Effects of Modified Otago Versus Action Observation on Strength, Mobility and Fall Risk in Diabetic Neuropathy
Comparative Effects of Modified Otago Exercises and Action Observation Training on Strength, Functional Mobility and Fall Risk in Patients With Diabetic Neuropathy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Riphah International University · Academic / Other
- Sex
- All
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To compare the Effects of Modified Otago Exercise and Action Observation Training on strength, functional mobility and fall risk in patients with diabetic neuropathy.
Detailed description
This study will be a randomized clinical trial. A total of 38 participants with diabetic neuropathy will be taken. By using non probability convenience sampling technique patients will be randomized and allocated into two intervention groups based on inclusion and exclusion criteria.Patients in group A will receive modified Otago exercises with conventional treatment.Patients in group B will receive Action Observation Training with conventional treatment.All participants will receive treatment of 40 minutes per session for 5 days a week for 8 weeks.The Michigan neuropathy screening instrument will be used for the assessment of diabetic neuropathy score.The strength,functional mobility and fall risk will be assessed by using 30 second chair stand test, Timed up and go test and fall efficacy scale.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | modified otago exercises | patients will receive modified Otago exercises with conventional treatment. |
| OTHER | Action Observation Training | Patients will receive Action Observation Training with conventional treatment. |
Timeline
- Start date
- 2024-05-01
- Primary completion
- 2024-09-01
- Completion
- 2024-09-01
- First posted
- 2024-06-14
- Last updated
- 2024-09-19
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT06459375. Inclusion in this directory is not an endorsement.